Watch CLX. Know when insiders buy.
One email the day a filing lands. Free.
CLX
CLOROX CO /DE/
84.77
−2.68 −3.06%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
81
PASS · shorts 81
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $10.3BP/E —DIV YIELD —FCF YIELD 3.71%REV TTM $6.8B −3.7%NET INCOME $756M +8.9%NET DEBT $1.3B52W 80.41 – 127.16SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Mar 31 | $1.7B | +0.1% | 43.2% | — | $187M | +0.5% | — | −$122M | $43M | −$165M | Apr 30 |
| Q2 2026 · Dec 31 | $1.7B | −0.8% | 43.2% | — | $157M | −18.7% | — | $311M | $42M | $269M | Feb 3 |
| Q1 2026 · Sep 30 | $1.4B | −18.9% | 41.7% | — | $80M | −19.2% | — | $93M | $36M | $57M | Nov 3 |
| Q4 2025 · Jun 30derived | $2B | +4.5% | 46.5% | — | $332M | +53.7% | — | $294M | $75M | $219M | Aug 8 |
| Q3 2025 · Mar 31 | $1.7B | −8.0% | 44.6% | — | $186M | — | — | $286M | $53M | $233M | Apr 30 |
| Q2 2025 · Dec 31 | $1.7B | −15.3% | 43.8% | — | $193M | +107.5% | — | $180M | $53M | $127M | Feb 3 |
| Q1 2025 · Sep 30 | $1.8B | +27.1% | 45.8% | — | $99M | +350.0% | — | $221M | $39M | $182M | Nov 3 |
| Q4 2024 · Jun 30derived | $1.9B | −5.7% | 46.5% | — | $216M | +22.7% | — | $340M | $81M | $259M | Aug 8 |
| Q3 2024 · Mar 31 | $1.8B | — | 42.2% | — | −$51M | — | — | $182M | $55M | $127M | May 5 |
| Q2 2024 · Dec 31 | $2B | — | 43.5% | — | $93M | — | — | $153M | $52M | $101M | Feb 3 |
| Q1 2024 · Sep 30 | $1.4B | — | 38.4% | — | $22M | — | — | $20M | $24M | −$4M | Oct 30 |
| Q4 2023 · Jun 30derived | $2B | — | 42.7% | — | $176M | — | — | $430M | $84M | $346M | Aug 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Jun 30 | $7.1B | 45.2% | — | $810M | 11.4% | — | $981M | $220M | $761M | $332M | $602M |
| FY2024 · to Jun 30 | $7.1B | 43.0% | — | $280M | 3.9% | — | $695M | $212M | $483M | $0 | $595M |
| FY2023 · to Jun 30 | $7.4B | 39.4% | — | $149M | 2.0% | — | $1.2B | $228M | $930M | $0 | $583M |
| FY2022 · to Jun 30 | $7.1B | 35.8% | — | $462M | 6.5% | — | $786M | $251M | $535M | $25M | $571M |
| FY2021 · to Jun 30 | $7.3B | 43.6% | — | $710M | 9.7% | — | $1.3B | $331M | $945M | $905M | $558M |
| FY2020 · to Jun 30 | $6.7B | 45.6% | — | $939M | 14.0% | — | $1.5B | $254M | $1.3B | $248M | $533M |
Every number comes from CLOROX CO /DE/'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.